Literature DB >> 2384160

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes.

A L Klibanov1, K Maruyama, V P Torchilin, L Huang.   

Abstract

Incorporation of dioleoyl N-(monomethoxy polyethyleneglycol succinyl)phosphatidylethanolamine (PEG-PE) into large unilamellar liposomes composed of egg phosphatidylcholine:cholesterol (1:1) does not significantly increase the content leakage when the liposomes are exposed to 90% human serum at 37 degrees C, yet the liposomes show a significant increase in the blood circulation half-life (t1/2 = 5 h) as compared to those without PEG-PE(t1/2 less than 30 min). The PEG-PE's activity to prolong the circulation time of liposomes is greater than that of the ganglioside GM1, a well-described glycolipid with this activity. Another amphipathic PEG derivative, PEG stearate, also prolongs the liposome circulation time, although its activity is less than that of GM1. Amphipathic PEGs may be useful for the sustained release and the targeted drug delivery by liposomes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2384160     DOI: 10.1016/0014-5793(90)81016-h

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  347 in total

1.  Technetium-99m labelled liposomes to image experimental arthritis.

Authors:  O C Boerman; W J Oyen; G Storm; M L Corvo; L van Bloois; J W van der Meer; F H Corstens
Journal:  Ann Rheum Dis       Date:  1997-06       Impact factor: 19.103

2.  Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.

Authors:  Jiang Chang; Archibald Paillard; Catherine Passirani; Marie Morille; Jean-Pierre Benoit; Didier Betbeder; Emmanuel Garcion
Journal:  Pharm Res       Date:  2011-12-14       Impact factor: 4.200

3.  Surface grafting of blood compatible zwitterionic poly(ethylene glycol) on diamond-like carbon-coated stent.

Authors:  Bong Soo Lee; Hong-Sub Shin; Kwideok Park; Dong Keun Han
Journal:  J Mater Sci Mater Med       Date:  2011-01-30       Impact factor: 3.896

Review 4.  Bone marrow-targeted liposomal carriers.

Authors:  Keitaro Sou; Beth Goins; Babatunde O Oyajobi; Bruno L Travi; William T Phillips
Journal:  Expert Opin Drug Deliv       Date:  2011-01-31       Impact factor: 6.648

5.  Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting.

Authors:  Lin Zhu; Pooja Kate; Vladimir P Torchilin
Journal:  ACS Nano       Date:  2012-03-14       Impact factor: 15.881

6.  Preformulation development of recombinant pegylated staphylokinase SY161 using statistical design.

Authors:  Frank Bedu-Addo; Randall Moreadith; Siddharth J Advant
Journal:  AAPS PharmSci       Date:  2002

7.  The effect of chain length on protein solubilization in polymer-based vesicles (polymersomes).

Authors:  Veena Pata; Nily Dan
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

8.  Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapy.

Authors:  Shutao Guo; Lei Miao; Yuhua Wang; Leaf Huang
Journal:  J Control Release       Date:  2013-11-23       Impact factor: 9.776

Review 9.  Application of polysaccharides for surface modification of nanomedicines.

Authors:  Kyung-Oh Doh; Yoon Yeo
Journal:  Ther Deliv       Date:  2012-12

Review 10.  Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.

Authors:  Srinivas Ramishetti; Leaf Huang
Journal:  Ther Deliv       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.